LARA SHEKERDEMIAN to Hypertension, Pulmonary
This is a "connection" page, showing publications LARA SHEKERDEMIAN has written about Hypertension, Pulmonary.
Connection Strength
1.009
-
The role of calcium channel blockers, steroids, anticoagulation, antiplatelet drugs, and endothelin receptor antagonists. Pediatr Crit Care Med. 2010 Mar; 11(2 Suppl):S46-52.
Score: 0.250
-
Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children. Am J Respir Crit Care Med. 2006 Nov 01; 174(9):1042-7.
Score: 0.196
-
Combination pharmacotherapy for severe neonatal pulmonary hypertension. J Paediatr Child Health. 2006 Apr; 42(4):219-20.
Score: 0.191
-
Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery. Intensive Care Med. 2003 Nov; 29(11):1996-2003.
Score: 0.161
-
Respiratory syncytial virus immunoprophylaxis in high-risk infants with heart disease. J Paediatr Child Health. 2012 May; 48(5):395-401.
Score: 0.073
-
Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome. Pediatr Res. 2010 Feb; 67(2):150-7.
Score: 0.062
-
Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome. Pediatr Res. 2004 Sep; 56(3):353-8.
Score: 0.042
-
Meconium aspiration syndrome and extracorporeal membrane oxygenation. Arch Dis Child Fetal Neonatal Ed. 2001 Jan; 84(1):F1-3.
Score: 0.033